<DOC>
	<DOCNO>NCT00004440</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine effect different dos ibuprofen neutrophil ( polymorphonuclear leukocyte ; PMN ) delivery mucosal surface ( oral mucosa ) patient cystic fibrosis healthy control . II . Determine duration effect ( possible rebound effect ) ibuprofen PMN delivery mucosal surface patient .</brief_summary>
	<brief_title>Study Ibuprofen Preserve Lung Function Patients With Cystic Fibrosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This open label study . Patients randomize 5 arm , consist 10 healthy volunteer 5 patient cystic fibrosis , base amount ibuprofen receive treatment period . The study period last least 15 day consist 3 period : baseline ( day 1-3 ) , treatment ( day 3-12 ) , recovery ( day 13-15 longer ) . During treatment period patient receive ibuprofen orally every 12 hour ( except control arm receive ibuprofen ) .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Confirmed diagnosis cystic fibrosis ( CF ) base : Sweat chloride great 60 mEq/L AND Typical pulmonary and/or gastrointestinal manifestation CF OR Healthy volunteer Prior/Concurrent Therapy At least 30 day since medication antineutrophil antiinflammatory effect ( e.g. , aspirin , nonsteroidal antiinflammatory drug [ NSAIDs ] , corticosteroid , macrolide antibiotic ) Patient Characteristics Age : Patients cystic fibrosis ( CF ) : 5 ; Healthy volunteer : 18 Hematopoietic : No significant history hematologic disease Hepatic : No significant history hepatic disease Renal : No significant history renal disease Cardiovascular : No significant history cardiovascular disease Pulmonary : See Disease Characteristics Neurologic : No significant history neurologic disease Other : Not pregnant ; No significant history peptic ulcer disease ; Patients CF free acute illness within 14 day ; No prior hypersensitivity NSAID</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2000</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>rare disease</keyword>
</DOC>